1
Mark W Grinstaff, Patrick Soon Shiong, Michael Wong, Paul A Sandford, Kenneth S Suslick, Neil P Desai: Composition useful for in vivo delivery of biologics and methods employing same. Vivorx Pharmaceuticals, Stephen E Pretty Schroeder Brueggemann & Clark Reiter, March 12, 1996: US05498421 (258 worldwide citation)

In accordance with the present invention, there are provided compositions useful for the in vivo delivery of a biologic, wherein the biologic is associated with a polymeric shell formulated from a biocompatible material. The biologic can be associated with the polymeric shell itself, and/or the biol ...


2
Neil P Desai, Patrick Soon Shiong, Paul A Sandford, Mark W Grinstaff, Kenneth S Suslick: Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor. VivoRx Pharmaceuticals, Stephen E Pretty Schroeder Brueggemann & Clark Reiter, August 8, 1995: US05439686 (191 worldwide citation)

In accordance with the present invention, there are provided compositions for the in vivo delivery of substantially water insoluble pharmacologically active agents (such as the anticancer drug taxol) in which the pharmacologically active agent is delivered in a soluble form or in the form of suspend ...


3
Neil P Desai, Chunlin Tao, Andrew Yang, Leslie Louie, Tianli Zheng, Zhiwen Yao, Patrick Soon Shiong, Shlomo Magdassi: Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof. Vivorx Pharmaceuticals, Stephen E Reiter, Gray Cary Ware & Freidenrich, June 29, 1999: US05916596 (178 worldwide citation)

In accordance with the present invention, there are provided compositions and methods useful for the in vivo delivery of substantially water insoluble pharmacologically active agents (such as the anticancer drug paclitaxel) in which the pharmacologically active agent is delivered in the form of susp ...


4
Farid Vaghefi: Dry powder inhaler. Vivorx Pharmaceuticals, Stephen E Reiter, Gray Cary Ware & Freidenrich, March 2, 1999: US05875776 (163 worldwide citation)

A dry powder inhaler includes a housing, a dosing cartridge, and a spacer. Within the housing are a source of pressurized gas, a pressure gauge, a metered valve controlled by a trigger, a safety valve, and an electrostatic charger also controlled by the trigger. The dosing cartridge contains individ ...


5
Neil P Desai, Patrick Soon Shiong: Methods and compositions useful for administration of chemotherapeutic agents. Vivorx Pharmaceuticals, Stephen E Reiter, Gray Cary Ware & Freidenrich, August 1, 2000: US06096331 (139 worldwide citation)

In accordance with the present invention, there are provided compositions and methods useful for the in vivo delivery of a pharmaceutically active agent, wherein the agent is associated with a polymeric biocompatible material.


6
Mark W Grinstaff, Patrick Soon Shiong, Michael Wong, Paul A Sandford, Kenneth S Suslick, Neil P Desai: Methods for the preparation of immunostimulating agents for in vivo delivery. Vivorx Pharmaceuticals, Stephen E Reiter, Gray Cary Ware & Freidenrich, September 9, 1997: US05665383 (135 worldwide citation)

In accordance with the present invention, there are provided compositions useful for the in vivo delivery of a biologic, wherein the biologic is associated with a polymeric shell formulated from a biocompatible material. The biologic can be associated with the polymeric shell itself, and/or the biol ...


7
Neil P Desai, Patrick Soon Shiong, Paul A Sandford, Mark W Grinstaff, Kenneth S Suslick: Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell. Vivorx Pharmaceuticals, Pretty Schroeder Brueggemann & Clark, November 8, 1994: US05362478 (133 worldwide citation)

In accordance with the present invention, compositions comprising fluorine-containing magnetic resonance imaging agent(s) contained within polymeric shells are provided. Invention compositions are useful, for example, as contrast agents for magnetic resonance imaging (MRI). Fluorinated compounds in ...


8
Mark W Grinstaff, Neil P Desai, Kenneth S Suslick, Patrick Soon Shiong, Paul A Sandford, Noma R Merideth: Method for the preparation of fluorocarbon-containing polymeric shells for medical imaging. Vivorx Pharmaceuticals, Stephen E Reiter, Pretty Schroeder Brueggemann & Clark, April 9, 1996: US05505932 (130 worldwide citation)

In accordance with the present invention, compositions comprising imaging agent(s) contained within polymeric shells are provided. Invention compositions are useful, for example, as contrast agents for magnetic resonance imaging (MRI), ultrasonography, and X-ray computer tomography. The polymeric sh ...


9
Mark W Grinstaff, Neil P Desai, Kenneth S Suslick, Patrick Soon Shiong, Paul A Sandford, Noma R Merideth: Non-fluorinated polymeric shells for medical imaging. Vivorx Pharmaceuticals, Stephen E Reiter, Pretty Schroeder Brueggemann & Clark, April 16, 1996: US05508021 (122 worldwide citation)

In accordance with the present invention compositions comprising imaging agent(s) contained within polymeric shells are provided. Invention compositions are useful, for example, as contrast agents for magnetic resonance imaging (MRI), ultrasonography, and X-ray computer tomography. The polymeric she ...


10
Patrick Soon Shiong, Neil P Desai, Mark W Grinstaff, Paul A Sandford, Kenneth S Suslick: Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor. VivoRx Pharmaceuticals, Stephen E Reiter, Pretty Schroeder Brueggemann & Clark, October 1, 1996: US05560933 (105 worldwide citation)

In accordance with the present invention, there are provided compositions for the in vivo delivery of substantially water insoluble pharmacologically active agents (such as the anticancer drug taxol) in which the pharmacologically active agent is delivered in a soluble form or in the form of suspend ...